动脉瘤下关节出血后生存的预测因素:长期观察队列研究
Svenja Odensass1, Meltem Gümüs1, Maryam Said2
1Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Hufelandstraße 55, Essen 45147, Germany.
Clinical neurology and neurosurgery
|November 1, 2024
概括
动脉瘤下arachnoid出血 (SAH) 后的死亡率仍然很高. 关键预测因素包括年龄,入院等级,Hijdra分数,内压力 (ICP) 增加和延迟脑缺血症 (DCI).
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 关键护理医学 关键护理医学
背景情况:
- 尽管在神经密集护理方面取得了进展,但神经瘤下关节出血 (SAH) 仍然具有显著的死亡率.
- 了解长期死亡率模式和预测因素对于改善患者的治疗结果至关重要.
研究的目的:
- 分析动脉瘤SAH患者的长期队列中的死亡率,时间和独立预测因素.
- 为了确定影响SAH后生存的因素,针对性干预措施.
主要方法:
- 一个单心观察队列研究包括在2003年1月至2016年6月期间连续治疗的SAH病例.
- 人口,临床和随访数据采集并使用单变量和多变量回归模型进行分析.
主要成果:
- 在992名患者中,总死亡率为21.4% (179人住院,33人随访期间).
- 确定了死亡率的独立预测因素:年龄>55岁,WFNS等级IV-V,Hijdra总分≥15,内压力 (ICP) 增加和延迟大脑缺血症 (DCI).
- 所有五种风险因素的存在与75%的病例死亡率相关,而没有任何风险因素的死亡率为2.5%.
结论:
- 最初的动脉瘤出血是主要的死亡率驱动因素,但ICP增加和DCI显著影响长期生存.
- 优化ICP和DCI的管理可能会降低SAH患者的整体死亡率.
- 识别和管理这些关键预测因素可以改善动脉瘤SAH后患者的预后.
相关概念视频
Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Introduction To Survival Analysis
184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
184


